Know Cancer

or
forgot password
  • cancer clinical trials in warren, MI

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    St. John Macomb Hospital
    Warren, Michigan 48093
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    St. John Macomb Hospital
    Warren, Michigan 48093
    Breast Cancer
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    St. John Macomb Hospital
    Warren, Michigan 48093
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    St. John Macomb Hospital
    Warren, Michigan 48093
    Esophageal Cancer, Gastric Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    St. John Macomb Hospital
    Warren, Michigan 48093
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    St. John Macomb Hospital
    Warren, Michigan 48093
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    St. John Macomb Hospital
    Warren, Michigan 48093
    Prostate Cancer
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Recurrent Mantle Cell Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    St. John Macomb Hospital
    Warren, Michigan 48093
    Chronic Myeloproliferative Disorders
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    St. John Macomb Hospital
    Warren, Michigan 48093
    Fallopian Tube Cancer, Ovarian Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
    St. John Macomb Hospital
    Warren, Michigan 48093
    Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer, Pain, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    St. John Macomb Hospital
    Warren, Michigan 48093
    Breast Cancer, Metastatic Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    St. John Macomb Hospital
    Warren, Michigan 48093
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    St. John Macomb Hospital
    Warren, Michigan 48093
    Lung Cancer
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Midwest Center for Dermatology and Cosmetic Surgery

    Trial Locations
    Midwest Center for Dermatology and Cosmetic Surgery
    Grekin Skin Institute
    Atopic Dermatitis
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Saint John Macomb-Oakland Hospital
    Warren, Michigan 48093
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma